Capstone Partners Reports 93.8% Surge in AI-Enabled Healthcare IT M&A

What You Should Know

• Middle-market investment banking firm Capstone Partners (a subsidiary of Huntington Bancshares Incorporated) released its September 2026 Healthcare Information Technology (IT) Market Update, documenting an acceleration in healthcare artificial intelligence dealmaking and B2B workflow automation.
• Overall Healthcare IT merger and acquisition (M&A) deal volume reached 179 announced or completed transactions year-to-date (YTD) 2026 (a 22.6% increase year-over-year), putting the sector on trajectory to surpass full-year 2025’s record total of 348 transactions.
• M&A targeting AI-enabled assets spiked 93.8% YOY to 62 transactions (accounting for 34.6% of all sector deals through June 30, 2026, compared to just 8.7% in 2022).
• Private equity (PE) dealmaking surged 27.1% YOY to represent 49.7% of all transaction volume, driven by a 29.3% increase in PE add-on acquisitions as financial sponsors tuck VC-backed AI platforms into existing electronic health record (EHR) and revenue cycle management (RCM) assets.
• Healthcare sector AI spending expanded rapidly across major operational domains: ambient clinical scribes reached $600M in 2025 (up from $250M in 2024), coding and billing reached $450M (up from $200M), while patient engagement and prior authorization expanded to $100M each.

Executive Briefing: Healthcare IT M&A & Private Equity Dynamics

The September 2026 Healthcare Information Technology Market Update from Capstone Partners details how AI-led workflow automation is restructuring capital allocation, valuation benchmarks, and transaction structures across healthcare IT.

The primary takeaway: Healthcare IT has exited the experimental pilot era and entered an aggressive consolidation phase where private equity sponsors and strategics are acquiring verticalized, agentic AI assets to automate high-cost, labor-intensive workflows and protect legacy platforms against functional obsolescence.

Key Transaction & Valuation Benchmarks (YTD 2026)

• Record-Paced M&A Volume: Sector M&A activity climbed 22.6% year-over-year to 179 announced or completed transactions through YTD 2026 (up from 146 in YTD 2025), positioning the full year to eclipse the record 348 deals logged in 2025.
• Surge in AI-Target Transactions: Deals involving AI-enabled targets reached 62 transactions—a 93.8% year-over-year spike from 32 in YTD 2025. AI-native or AI-enabled companies now represent 34.6% of all sector M&A, compared to just 8.7% in 2022.
• Private Equity Add-On Acceleration: While strategics accounted for a slight majority of deals (50.3%), financial sponsors surged 27.1% year-over-year to capture 49.7% of total volume. PE add-on acquisitions grew 29.3%, as sponsors actively bolted venture-backed AI tuck-ins onto existing portfolio platforms to protect against competitive obsolescence.
• Valuation Multiple Expansion: Average M&A enterprise valuation multiples for 2025–YTD 2026 reached 7.3x EV/Revenue, rebounding sharply from 4.6x in 2023–2024 and surpassing the 2021–2022 pandemic peak (6.4x) due to intense competition for high-performing B2B AI assets.
• Elevation in Average Enterprise Value: The average deal value climbed to $686.3M (up from $446.8M in 2023–2024), driven by large-scale transactions (greater than $500M EV) that now make up 23.2% of all disclosed deals.
• Dominance of B2B Infrastructure: Dealmaking targeting B2B infrastructure (hospitals, health systems, physician practices, and payers) grew 13.8% year-over-year, accounting for 73.7% of all Healthcare IT transactions YTD.

Capital Allocation Dynamics: Growth Moderation vs. AI Valuation Flight

The equity financing landscape has bifurcated between broader market caution and intense capital concentration around proven AI infrastructure:

• Contraction in Middle-Market Growth Equity: Overall middle-market growth financing rounds fell 32.7% year-over-year to 49 deals, with total growth capital raised dropping 41.7% to $2.3 billion.
• Extreme Concentration in AI Platforms: Despite top-line financing moderation, AI-enabled healthcare companies absorbed a record 87.9% of total sector equity funding.
• Valuation Appreciation Divergence: While overall middle-market median pre-money valuations appreciated 12.9% to $289.0M, companies incorporating AI into their core software and services saw a 116.3% year-over-year surge in median pre-money valuation (headlined by OpenEvidence’s $250M Series D at an $11.8B pre-money valuation).

Workflow Automation Acceleration: Spend Growth by Category

Citing findings from Menlo Ventures, Capstone highlights that healthcare has deployed AI at 2.2x the rate of the broader U.S. economy, with 22% of healthcare organizations implementing domain-specific AI tools (up 7x from 2024). Total annual enterprise AI investment tripled year-over-year to $1.4 billion, heavily concentrating where operational ROI is directly measurable:

• Ambient Clinical Scribing: Enterprise spending expanded from $250M in 2024 to $600M in 2025 (+140%), rapidly evolving from an administrative convenience into the primary point-of-care front door for clinical intelligence and downstream order execution.
• Coding & Billing (RCM): Rose from $200M in 2024 to $450M in 2025 (+125%), driven by provider demand for autonomous coding, charge capture, and accounts receivable automation to displace manual, offshore business process outsourcing (BPO).
• Prior Authorization Automation: Grew tenfold from $10M in 2024 to $100M in 2025 (+900%), accelerating as health systems deploy software to connect unstructured EHR notes directly with codified payer coverage policies.
• Patient Engagement: Surged from $5M to $100M (+1,900%), as organizations shifted from passive MyChart push alerts toward conversational, agentic scheduling and inbound voice assistants.
• Payer Engagement & Operations: Grew to $75M (+200%) and $50M (+400%) respectively, reflecting commercial and managed care plans automating member risk stratification, care-gap closure, and claims intake operations.

Notable M&A Transactions & Sector Implications

The report outlines several high-impact integrations demonstrating how acquirers are consolidating specialized technical talent and automated workflows:

• Clarify Health Acquired Loyal Health (June 2026): Merged Clarify’s Meridian network intelligence platform (referral leakage and provider performance benchmarking) with Loyal’s Care Activation Platform (omnichannel engagement and scheduling) to establish an end-to-end patient steering platform.
• Med-Metrix Acquired Vitalware ($147M EV / 4.0x Revenue, June 2026): Consolidated middle-revenue-cycle operations by pairing hospital RCM services with cloud-based chargemaster management and revenue integrity software.
• IKS Health Acquired TruBridge ($547M EV / 1.6x Revenue / 15.7x EBITDA, April 2026): Provider enablement leader acquired TruBridge’s rural and community hospital EHR and billing footprint to cross-sell tech-enabled administrative operations.
• TELCOR Acquired Sample Healthcare (April 2026): Point-of-care and laboratory RCM provider integrated Sample’s AI agents to automate document processing, clearinghouse tasks, and manual payer portal interactions.
• Universal Health Services Acquired Talkspace ($833.2M EV / 3.6x Revenue, March 2026): Acute behavioral health operator acquired a nationwide tele-psychiatry network to build an integrated ambulatory feeder channel.
• OpenAI Acquired Torch Health ($100M, January 2026): Frontier AI lab acquired longitudinal medical memory software to synthesize fragmented health records into unified clinical reasoning foundations.
• Saisystems Health Recapitalized with Serent Capital (December 2025): Capstone advised Saisystems—an end-to-end RCM and EHR platform purpose-built for post-acute and skilled nursing facility (SNFist) providers—on its majority transaction with Serent Capital. Saisystems demonstrated clear provider ROI: a 42% increase in collections per claim, 26% faster first-billed collections, and a 15.5% expansion in clinical patient volume.

Strategic Context and Capital Allocation Synthesis

This investment banking update provides clear context for recent market moves:

• Enterprise Scribing Scale (Heidi & Abridge): Annual spend on ambient documentation and clinical AI grew from $250M to $600M in a single year. With basic ambient transcription commoditizing rapidly, platforms with dedicated capital facilities and deep EHR hooks are expanding into downstream EHR order entry and clinical decision support to lock in multi-year enterprise contracts.
• Vertical EMR Rollups (Venture Medical/Medipyxis & Serent/Saisystems): In subsegments facing intensified reimbursement audits and prior authorization rules (such as post-acute SNFs and wound care under WISeR), generic EHRs leave practices vulnerable. Private equity sponsors and clinical operators are acquiring vertical-specific EMR/RCM platforms to bundle compliance-aware clinical documentation directly with supply chain logistics.
• Upstream RCM Consolidation (Oracle Health & Ensemble/Penelope): With coding and billing spend jumping to $450M and prior authorization surging to $100M, provider CFOs are prioritizing upstream automation over downstream denial appeals. Moving real-time payer policy intelligence to the point of care provides the immediate, auditable return on investment required in an environment where healthcare IT M&A multiples demand top-tier financial performance.